Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure.

Data Brief

Hôpital Paul-Doumer, Assistance Publique des Hôpitaux de Paris (AP-HP), 1 rue de l'hôpital, Liancourt, France.

Published: April 2021

Pentobarbital is used as an alternative in pediatric sedative imaging procedures. Pentobarbital is only available as pharmaceutical powder. Regardless of its clinical use, its manipulation is necessary byhospital pharmacists that must prepare adapted dosage forms for pediatrics. The data presented in this article suggest that extemporaneous suspensions of sodium pentobarbital in oral liquid base are stable for at least 120 days.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910507PMC
http://dx.doi.org/10.1016/j.dib.2021.106884DOI Listing

Publication Analysis

Top Keywords

stability data
4
data extemporaneous
4
extemporaneous oral
4
oral suspension
4
pentobarbital
4
suspension pentobarbital
4
pentobarbital syrspend
4
syrspend alka
4
alka imaging
4
imaging sedation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!